Clinical trials
Alzheimer Disease trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| GlaxoSmithKline | 3 |
| Eli Lilly and Company | 2 |
| Hunter-Fleming Ltd | 1 |
| Jaslok Hospital and Research Centre | 1 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 1 |
| National Institute of Mental Health and Neuro Sciences, India | 1 |
| Novartis Pharmaceuticals | 1 |
| Pharmazz, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 15 |
| Dementia | 3 |
| Cognitive Dysfunction | 2 |
| Lymphoma, Follicular | 1 |
| Psychomotor Agitation | 1 |
| Psychotic Disorders | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.